Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pediatrics, |
RCV000844834 | SCV000966113 | likely pathogenic | Deficiency of acetyl-CoA acetyltransferase | 2019-05-05 | criteria provided, single submitter | research | |
ARUP Laboratories, |
RCV000844834 | SCV004562707 | likely pathogenic | Deficiency of acetyl-CoA acetyltransferase | 2023-10-10 | criteria provided, single submitter | clinical testing | The ACAT1 c.1059T>A; p.Asn353Lys variant (rs1591374629) is reported in the literature in one individual affected with alpha-methylacetoacetic aciduria (Abdelkreem 2019, Sakurai 2007). This variant is also reported in ClinVar (Variation ID: 666525). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. Additionally, another variant at this codon (c.1059T>G; p.Asn353Lys) has been reported in an individual with alpha-methylacetoacetic aciduria and is considered likely pathogenic (Paquay 2017). Functional analysis of the variant protein show a loss of catalytic activity (Abdelkreem 2019, Sakurai 2007). Computational analyses predict that this variant is deleterious (REVEL: 0.856). Based on available information, this variant is considered to be likely pathogenic. References: Abdelkreem E et al. Mutation update on ACAT1 variants associated with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency. Hum Mutat. 2019 Oct;40(10):1641-1663. PMID: 31268215. Paquay S et al. Mitochondrial acetoacetyl-CoA thiolase deficiency: basal ganglia impairment may occur independently of ketoacidosis. J Inherit Metab Dis. 2017 May;40(3):415-422. PMID: 28255778. Sakurai S et al. Kinetic and expression analyses of seven novel mutations in mitochondrial acetoacetyl-CoA thiolase (T2): identification of a Km mutant and an analysis of the mutational sites in the structure. Mol Genet Metab. 2007 Apr;90(4):370-8. PMID: 17236799. |